Brian Buntz

Picture a nuclear-powered surgical robot targeting glioblastoma. Or imagine hijacking a botfly larva to perform delicate internal interventions. These scenarios may sound far out, but Endiatx CEO Torrey Smith talks about them as if describing an ambitious home improvement project — challenging but entirely feasible with the right approach and tools. Though these scenarios sound…

[Updated on December 11, 2024 to reflect nearly 150,000 layoffs across more than 525 companies based on latest industry data] For many workers, it pays to have a job in an R&D or STEM-heavy field. The Bureau of Labor Statistics forecasts 10.4% growth in STEM jobs through 2033, more than double the overall employment growth…

Life sciences executives are entering 2025 with data-driven optimism, according to Deloitte’s newly released “2025 Life Sciences Outlook.” Survey findings from 150 global C-suite executives show that 75% remain upbeat about the year ahead, with 68% anticipating revenue increases and 57% expecting margin expansions. Two key factors emerge from executive interviews: enhanced clarity following the…

Google’s unveiling of the Willow quantum processor could go down in history as a big moment in the pursuit of fault-tolerant quantum computing. A BBC article called the advance “mind-boggling.” And in many respects, it is. The processor completed a specialized computation in five minutes that would theoretically take today’s fastest supercomputers 10 septillion years—a…

While the term “biotechnology” was coined in 1919, “techbio” dates back roughly a century after that. Around 2019, the VC firm Artis Ventures set up a venture capital fund named Artis techbio with the aim of uniting software, computational biology, and drug development into a cohesive framework. The ambition behind this idea has sometimes surpassed…

For Avandra CEO and founder Ryan Tarzy, the potential of AI in healthcare is personal. He lost his father to pancreatic cancer, a disease often caught too late in the United States. At the recent Radiological Society of North America (RSNA) conference, he encountered a telling example of what emerging medical tech can achieve. “At…

A good number of organizations rushing to deploy AI in pharmaceutical and genomics research have their priorities backward. They need not only a solid data infrastructure but also true data savviness before forging ahead with deep learning or large language models, argues Stavros Papadopoulos, CEO and founder of TileDB, the developer of data platform for…

This week in AI brings both breakthroughs and reality checks. DeepMind’s weather forecasting model demonstrates high accuracy at 15-day predictions, potentially transforming climate science and disaster preparedness if it can live up to the billing. Meanwhile, OpenAI’s new o1 model launch reveals the current limitations of AI reasoning — despite performance gains on academic tasks,…

If you read much about AI, you’ve likely noticed the growing number of models capable of “reasoning” and acting autonomously. This isn’t just about chatbots; it’s transforming scientific discovery. Google DeepMind recently launched a 15-day weather forecasting agent, bringing new levels of accuracy to complex atmospheric modeling. OpenAI’s latest reasoning model, o1, has demonstrated potential…

A team of researchers at the Allen Institute for AI and UC San Diego have introduced a climate modeling approach boasting 25× speed-ups and associated energy savings over the emulated physics-based model FV3GFS. Specifically, the method takes about 2 hours and 56 minutes to run a 10-year simulation The physics-based FV3GFS model takes about 78 hours…

As many as 2.1 million manufacturing jobs could go unfilled by 2030, according to an influential 2021 projection from Deloitte and The Manufacturing Institute. Meanwhile, the Bureau of Labor Statistics projects a growth rate of 0.1% from 2023 to 2030, yielding only 110,000 projected new jobs, resulting in a potential overall change from 12.9 million…

Amazon is unveiling its multimodal “Olympus” AI model featuring advanced video analysis capabilities, with development versions ranging from 400 billion to 2 trillion parameters. In other news, Mount Sinai Health System opened a 65,000-square-foot AI research center housing 40 Principal Investigators and 250 technical staff, while Recursion Pharmaceuticals completed its merger with Exscientia, reporting a…

2024 may potentially be the year that genAI hype peaked. But the momentum around the subject continues to be intense. In a query of Elsevier’s Scopus database, generative AI had a CAGR of 313.3% from 2019 when there were four publications on the subject. As of November 27, there were 4,821 papers featuring the subject…

GLP-1 juggernauts Eli Lilly and Novo Nordisk, whose combined $1.18 trillion market cap now exceeds Johnson & Johnson, AbbVie, and Merck combined, have staked their claim as stock market darlings. This momentum is particularly evident in Novo Nordisk’s remarkable trajectory, reaching a $604 billion market capitalization by March 2024 and securing its position as the…

Tech giants are assembling AI supercomputers of unprecedented scale. Microsoft, Meta, Amazon, and Elon Musk’s xAI are building clusters boasting 100,000 or more H100 GPUs, with xAI planning to double its Colossus system to 200,000 GPUs — including the upcoming H200 model. To put this in perspective, OpenAI reportedly trained GPT-4 using roughly 25,000 A100…

Amazon recently doubled down on its Anthropic investment with an additional $4 billion, while NVIDIA reported another quarter of remarkable growth with sales hitting $35.1 billion. Meanwhile, a debate emerged at the Cerebral Valley AI Summit about whether AI development is hitting a scaling wall, with industry leaders like Anthropic’s Dario Amodei and Scale AI’s Alexandr…

Imagine a future where needing a new heart means you become your own donor. “It’s going to be your cells, your design—an exact replica of your heart, only made healthy,” said Steven Levine, Ph.D., senior director of virtual human modeling at Dassault Systèmes, in a recent interview. For Levine, the goal of transforming cardiac care…

Industrial and commercial sectors often measure innovation by market capitalization and R&D spending, but these metrics fail to capture the full picture. Tech companies dominate market headlines with AI product launches and chip releases — and our own ranking of most innovative firms of 2024. In addition, tech firms currently hold the top market cap…

Yes, questions remain about whether AI chipmaker NVIDIA can maintain its momentum in 2025. NVIDIA’s upcoming Blackwell AI chips have encountered thermal problems when integrated into server racks designed to house up to 72 units. Despite these recent technical hurdles, the company remains an innovation juggernaut. 1. Why NVIDIA is the R&D leader of 2024…

For the first time, the Chinese Academy of Sciences (CAS) has eclipsed Harvard University as the world’s leading institution in scientific research output, according to the 2024 Nature Index, which is based on high-quality research outputs. Several China-based research organizations have jumped in the rankings, with seven of them rounding out the top 10 while…

From AMD cutting 4% of its workers as it continues an AI push to LAMs, AI continues to shake up the technology landscape. While a Reuters report suggests that genAI progress may be cooling, several prominent figures such as Anthropic CEO Dario Amodei and former Google CEO Eric Schmidt have refuted it. OpenAI explores novel…

The race to create AI agents that can operate computers and perform tasks more autonomously is ramping up, with OpenAI preparing to launch its “Operator” tool in January, according to Bloomberg. The tool, which would allow AI to perform tasks like fill out spreadsheets, book travel or write code on behalf of users, will initially…

From enterprise software to drug discovery, artificial intelligence is triggering seismic shifts in corporate R&D strategies. SAP is investing €2 billion annually in AI while planning to cut up to 10,000 jobs. OpenAI is pivoting from its nonprofit roots toward a for-profit model valued at $80 billion. Hardware giants like Intel and AMD are slashing…

It was the best of times, it was the worst of times for hardware companies. For a handful of hardware companies, 2024 was a tough year. Intel, Dell, AMD, IBM jointly cut more than 23,000 jobs this year. Intel alone slashed 15,000 positions as it targeted $10 billion in cost savings by 2025. The PC…

In many respects, 2024 was a year of building upon the foundations laid by previous technological and scientific advances. While AI continued to evolve at a rapid clip, progress was in many ways more incremental than last year when GPT-4 redefined expectations for genAI. But AI continues to make definable improvements across a range of…